Application of static magnetic fields versus copper for the relief of pain in osteoarthritis: a randomised double-blind placebo controlled trial

ISRCTN	ISRCTN18518978
DOI	https://doi.org/10.1186/ISRCTN18518978
Secondary identifying numbers	N/A

Submission date: 15/10/2004
Registration date: 06/12/2004
Last edited: 07/03/2017

Recruitment status: No longer recruiting
Overall study status: Completed
Condition category: Musculoskeletal Diseases

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Mr Stewart Richmond
Scientific

301 Hertford Building
The University of Hull
Cottingham Road
Hull
HU6 7RX
United Kingdom

Phone	+44 (0)1482 463681
Email	s.j.richmond@hull.ac.uk

Study information

Study design	Randomised double-blind placebo controlled trial
Primary study design	Interventional
Secondary study design	Randomised controlled trial
Study setting(s)	Not specified
Study type	Not Specified
Participant information sheet	Trial participant information is available on http://www.hull.ac.uk/macropod/info.htm
Scientific title	Application of static magnetic fields versus copper for the relief of pain in osteoarthritis: a randomised double-blind placebo controlled trial
Study acronym	MACROPOD (Magnetic And Copper therapy for the Relief Of Pain in Osteoarthritis: a randomised Double-blind placebo-controlled trial)
Study objectives	Study aims: 1. To investigate the therapeutic efficacy of commercially available magnetic and copper bracelets as an adjunct to practitioner led management of osteoarthritic pain 2. To evaluate the potential economic impact of static magnetic therapy (SMT) and to gather evidence relating to safety of the devices under investigation 3. To address both local and more widespread needs in terms of providing rigorous scientific evidence relating to the efficacy of magnetic and copper bracelets
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Osteoarthritis
Intervention	The trial will use a randomised double-blind placebo controlled crossover design. All participants will undertake one of four randomly allocated treatment sequences consisting of four phases (one active and three control). During the active phase participants will wear the MagnaMax® static magnetic device for a period of four weeks. During the three control (placebo) phases, which will each last for four weeks, all participants will in turn wear: an otherwise identical low strength static magnetic device, a demagnetised device and a copper bracelet.
Intervention type	Other
Primary outcome measure	Not provided at time of registration
Secondary outcome measures	Not provided at time of registration
Overall study start date	01/01/2005
Completion date	31/12/2006

Eligibility

Participant type(s)	Patient
Age group	Adult
Lower age limit	18 Years
Sex	Not Specified
Target number of participants	Between 48 to 60 patients identified as suffering from osteoarthritis within primary care.
Key inclusion criteria	1. 18 years of age or over 2. Diagnosis of osteoarthritis 3. In receipt of prescribed non-steroidal anti-inflammatory drugs (NSAIDs) and opioid/opioid compound analgesic medication 4. Responsible for administering own medication 5. Reporting pain associated with osteoarthritis
Key exclusion criteria	1. Confounding medical condition/disease 2. Pain lasting less than 6 weeks in total duration prior to recruitment 3. Pacemaker, insulin pump or similar device fitted 4. Pregnant women
Date of first enrolment	01/01/2005
Date of final enrolment	31/12/2006

Locations

Countries of recruitment

England
United Kingdom

Study participating centre

301 Hertford Building

Hull
HU6 7RX
United Kingdom

Sponsor information

The University of Hull (UK)
University/education

Cottingham Road
Hull
HU6 7RX
England
United Kingdom

Phone	+44 (0)1482 463681
Email	s.j.richmond@hull.ac.uk
Website	http://www.hull.ac.uk
"ROR"	https://ror.org/04nkhwh30

Funders

Funder type

Hospital/treatment centre

Wolds Primary Care Research Network (WOREN) and West Hull Primary Care Trust (uk)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
Publication and dissemination plan	Not provided at time of registration
IPD sharing plan

Editorial Notes

07/03/2017: No publications found in PubMed, verifying study status with principal investigator